Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency Virus–Associated Tuberculosis

Naomi Walker, Charlotte Schutz, Amy Ward, David Barr, Charles Opondo, Muki Shey, Paul T. Elkington, Katalin A. Wilkinson, Robert J. Wilkinson, Graeme Meintjes

Research output: Contribution to journalArticlepeer-review

Abstract

Mortality from human immunodeficiency virus (HIV)–associated tuberculosis (TB) is high, particularly among hospitalized patients. In 433 people with HIV hospitalized with symptoms of TB, we investigated plasma matrix metalloproteinases (MMP) and matrix-derived biomarkers in relation to TB diagnosis, mortality, and Mycobacterium tuberculosis (Mtb) bloodstream infection (BSI). Compared to other diagnoses, MMP-8 was elevated in confirmed TB and in Mtb-BSI, positively correlating with extracellular matrix breakdown products. Baseline MMP-3, -7, -8, -10, and PIIINP were associated with Mtb-BSI and 12-week mortality. These findings implicate MMP dysregulation in pathophysiology of advanced HIV-TB and support MMP inhibition as a host-directed therapeutic strategy for HIV-TB.

Original languageEnglish
Pages (from-to)109-114
Number of pages6
JournalJournal of Infectious Diseases
Volume231
Issue number1
Early online date2 Sept 2024
DOIs
Publication statusPublished - 15 Jan 2025

Keywords

  • biomarker
  • HIV
  • matrix degradation product
  • matrix metalloproteinase
  • mortality
  • procollagen III N-terminal propeptide
  • tuberculosis

Fingerprint

Dive into the research topics of 'Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency Virus–Associated Tuberculosis'. Together they form a unique fingerprint.

Cite this